Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
- Seok Jin Kim
- , Dok Hyun Yoon
- , Hye Jin Kang
- , Jin Seok Kim
- , Seong Kyu Park
- , Hyo Jung Kim
- , Jeeyun Lee
- , Baek Yeol Ryoo
- , Young Hyeh Ko
- , Jooryung Huh
- , Woo Ick Yang
- , Hee Kyung Kim
- , Soo Kee Min
- , Seung Sook Lee
- , In Gu Do
- , Cheolwon Suh
- , Won Seog Kim
Research output: Contribution to journal › Article › peer-review
113
Link opens in a new tab
Scopus
citations